In your state
Delaware

In the development of new medicines, clinical trials are conducted to prove therapeutic safety and effectiveness and compile the evidence needed for the Food and Drug Administration (FDA) to approve treatments. And the biopharmaceutical sector is committed to bringing new treatments and cures to patients. This commitment to innovation supports high-quality jobs and is a vital part of every state’s economy and our global economic competitiveness.

Economic Impact In Your State: Delaware

$2.8B

Total output supported by biopharmaceutical sector

$164.5M

Tax Revenue Generated

8,597

Total Jobs

4,267

Direct Jobs

Clinical Trials in Your State: Delaware

68

TOTAL CLINICAL TRIALS

$7.3 million

INVESTED IN CLINICAL TRIALS

770

TOTAL ECONOMIC IMPACT OF CLINICAL TRIAL INVESTMENTS

$18.1 million

INVESTED IN CLINICAL TRIALS

Programs and Initiatives in Your State: Delaware


State programs and initiatives to promote biopharmaceutical industry development

    ACCELERATING INNOVATION, COMMERCIALIZATION & ENTREPRENEURIAL DEVELOPMENT

    BUILDING ADVANCED MANUFACTURING

    BUILDING RESEARCH CAPACITY AND/OR R&D INFRASTRUCTURE

    ECONOMIC INNOVATION INCENTIVES

    STEM EDUCATION & WORKFORCE DEVELOPMENT

    TARGETED STRATEGIES

    VENTURE FINANCING

State Innovation Indicators

19

Patents per 1,000 people in Science & Engineering

13.4%

Percentage of Workforce Employed in High-Tech Jobs

This website uses cookies and other tracking technologies to optimize performance, preferences, usage, and statistics. By clicking “Accept All”, you consent to store on your device the cookies and other tracking technologies that require consent. You can tailor or change your preferences by clicking “Manage My Cookies”. You can check our privacy policy for more information.